Digestive Cancer Clinical Trials

9 recruiting

Digestive Cancer Trials at a Glance

11 actively recruiting trials for digestive cancer are listed on ClinicalTrialsFinder across 6 cities in 4 countries. The largest study group is Not Applicable with 7 trials, with the heaviest enrollment activity in Poitiers, Dijon, and Lyon. Lead sponsors running digestive cancer studies include UNICANCER, Institut du Cancer de Montpellier - Val d'Aurelle, and GERCOR - Multidisciplinary Oncology Cooperative Group.

Browse digestive cancer trials by phase

Treatments under study

About Digestive Cancer Clinical Trials

Looking for clinical trials for Digestive Cancer? There are currently 9 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Digestive Cancer trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Digestive Cancer clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 111 of 11 trials

Recruiting
Phase 2

Dose Individualization of Chemotherapy in Patients With Gastrointestinal Cancers Lacking a Specific Liver Enzyme

Digestive Cancer
UNICANCER400 enrolled41 locationsNCT06475352
Recruiting
Not Applicable

Target-specific immunoPET Imaging of Digestive System Carcinoma

MalignancyLiver CancerPancreatic Cancer+12 more
RenJi Hospital400 enrolled1 locationNCT06715839
Recruiting
Not Applicable

Interest of Circulating Tumor DNA in Digestive and Gynecologic/Breast Cancer

Breast CancerGynecologic CancerCirculating Tumor DNA+2 more
Poitiers University Hospital1,000 enrolled1 locationNCT04530890
Recruiting
Not Applicable

Multicomponent Prehabilitation and Outcomes in Elderly Patients With Frailty

OutcomesSurgeryDigestive Cancer+3 more
Peking University First Hospital540 enrolled1 locationNCT04715581
Recruiting
Phase 2

Efficacy of Neoadjuvant Chemotherapy in Terms of DFS in Patients With Localized Digestive Neuroendocrine Carcinomas

Digestive CancerNeuroendocrine Carcinoma
GERCOR - Multidisciplinary Oncology Cooperative Group78 enrolled14 locationsNCT04268121
Recruiting
Not Applicable

Identification of Innovative Biomarkers Related to the Immune System or Tumor Microenvironment to Promote the Efficacy of Immunotherapies

Advanced Digestive CancerAdvanced Gynecologic Cancer
Centre Hospitalier Universitaire de Besancon700 enrolled2 locationsNCT06626269
Recruiting
Not Applicable

TARGETed Therapy Drug MONITOring in DIGestive Oncology

Hepatocellular CarcinomaMetastatic Colorectal CancerNeuroendocrine Tumors+2 more
UNICANCER330 enrolled29 locationsNCT05443087
Recruiting
Not Applicable

Psychoneurological Symptom Cluster in Oncology

Breast CancerCancerDigestive Cancer
University of Liege500 enrolled1 locationNCT05867966
Recruiting
Not Applicable

Development of Clinical and Biological Database

Breast CancerSarcomaGynecologic Cancer+1 more
Institut du Cancer de Montpellier - Val d'Aurelle4,000 enrolled1 locationNCT03449264
Recruiting

Spanish Registry of Digestive Tumours RETUD

Pancreatic CancerRectal CancerBile Duct Cancer+3 more
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)20,000 enrolled1 locationNCT06711211
Recruiting
Early Phase 1

A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Advanced Solid Tumors

Breast CancerSarcomaLung Cancer+7 more
Shanghai Yunying Medical Technology20 enrolled1 locationNCT05961111